162 related articles for article (PubMed ID: 3510727)
1. Expression of p21 ras oncoproteins in human cancers.
Tanaka T; Slamon DJ; Battifora H; Cline MJ
Cancer Res; 1986 Mar; 46(3):1465-70. PubMed ID: 3510727
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
[TBL] [Abstract][Full Text] [Related]
4. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse.
Pullano TG; Sinn E; Carney WP
Oncogene; 1989 Aug; 4(8):1003-8. PubMed ID: 2474786
[TBL] [Abstract][Full Text] [Related]
5. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
Ward JM; Perantoni AO; Santos E
Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
[TBL] [Abstract][Full Text] [Related]
6. Ras p21 onco-protein in the sera of mice carrying an experimentally induced tumor and in human cancer patients.
Kakkanas A; Spandidos DA
In Vivo; 1990; 4(2):115-20. PubMed ID: 2129802
[TBL] [Abstract][Full Text] [Related]
7. Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis.
Tahara E; Yasui W; Taniyama K; Ochiai A; Yamamoto T; Nakajo S; Yamamoto M
Jpn J Cancer Res; 1986 Jun; 77(6):517-22. PubMed ID: 3089984
[TBL] [Abstract][Full Text] [Related]
8. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
9. Modification of Ha-ras oncogene p21 expression and cell cycle progression in the human colonic cancer cell line HT-29.
Czerniak B; Herz F; Wersto RP; Koss LG
Cancer Res; 1987 Jun; 47(11):2826-30. PubMed ID: 3105868
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody highly sensitive for the detection of ras p21 in immunoblotting analysis.
Kanai T; Hirohashi S; Noguchi M; Shimoyama Y; Shimosato Y; Noguchi S; Nishimura S; Abe O
Jpn J Cancer Res; 1987 Dec; 78(12):1314-8. PubMed ID: 3123435
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of the ras oncogene expression in human breast lesions.
Agnantis NJ; Petraki C; Markoulatos P; Spandidos DA
Anticancer Res; 1986; 6(5):1157-60. PubMed ID: 3541779
[TBL] [Abstract][Full Text] [Related]
12. Characterization of monoclonal antibodies specific to the activated ras p21 with aspartic acid at position 13.
La Vecchio JA; Hamer PJ; Ng SC; Trimpe KL; Carney WP
Oncogene; 1990 Aug; 5(8):1173-8. PubMed ID: 2202949
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of p21 proteins from various cell types by two-dimensional gel electrophoresis.
Feuerstein N; Ali IU
J Cell Biochem; 1985; 29(3):253-63. PubMed ID: 3001111
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer.
Clair T; Miller WR; Cho-Chung YS
Cancer Res; 1987 Oct; 47(20):5290-3. PubMed ID: 3308076
[TBL] [Abstract][Full Text] [Related]
15. Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers.
Yoshida K; Hamatani K; Koide H; Ikeda H; Nakamura N; Akiyama M; Tsuchiyama H; Nakayama E; Shiku H
Cancer Res; 1988 Oct; 48(19):5503-9. PubMed ID: 3046740
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
Pechoux C; Chardonnet Y; Chignol MC; Noël P
Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical localization of p21 ras gene product in human hepatoma cell lines and corresponding tumors in athymic mice.
Matarazzo M; Faraggiana T; Donato MF; Paronetto F
J Exp Pathol; 1987; 3(3):305-15. PubMed ID: 2835467
[TBL] [Abstract][Full Text] [Related]
18. The c-K-ras gene and human cancer (review).
Kahn S; Yamamoto F; Almoguera C; Winter E; Forrester K; Jordano J; Perucho M
Anticancer Res; 1987; 7(4A):639-52. PubMed ID: 3310850
[TBL] [Abstract][Full Text] [Related]
19. The v-mos and c-Ha-ras oncoproteins exert similar effects on the pattern of protein synthesis.
Klemenz R; Hoffmann S; Jaggi R; Werenskiold AK
Oncogene; 1989 Jun; 4(6):799-803. PubMed ID: 2525241
[TBL] [Abstract][Full Text] [Related]
20. ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues.
Thor A; Ohuchi N; Hand PH; Callahan R; Weeks MO; Theillet C; Lidereau R; Escot C; Page DL; Vilasi V
Lab Invest; 1986 Dec; 55(6):603-15. PubMed ID: 2431221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
